miRNAs as potential game-changers in renal cell carcinoma: Future clinical and medicinal uses

Renal cell carcinoma (RCC) has the highest mortality rate of all genitourinary cancers, and its prevalence has grown over time. While RCC can be surgically treated and recurrence is only probable in a tiny proportion of patients, early diagnosis is crucial. Mutations in a large number of oncogenes a...

Full description

Saved in:

Bibliographic Details
Published in:	Pathology, research and practice Vol. 245; p. 154439
Main Authors:	Elballal, Mohammed S., Sallam, Al-Aliaa M., Elesawy, Ahmed E., Shahin, Reem K., Midan, Heba M., Elrebehy, Mahmoud A., Elazazy, Ola, El-Boghdady, Rawnaa Mohammed, Blasy, Shaimaa Hassan, Amer, Nada Mahmoud, Farid, Hadeer Ibrahim, Mohammed, Dina Ashraf, Ahmed, Shaymaa Adly, Mohamed, Sally Samir, Doghish, Ahmed S.
Format:	Journal Article
Language:	English
Published:	Germany Elsevier GmbH 01-05-2023
Subjects:	Biomarkers, Tumor - metabolism Carcinoma, Renal Cell - genetics Carcinoma, Renal Cell - metabolism Carcinoma, Renal Cell - therapy Drug resistance Gene Expression Regulation, Neoplastic Humans Kidney Neoplasms - genetics Kidney Neoplasms - metabolism Kidney Neoplasms - therapy MicroRNAs - metabolism MiRNA Oncogenes P53 Renal cell carcinoma VEGF RAS SERPINE1 PTEN FOXM1 Drug resistance ETS1 NF-κB PI3K OCT2 mTOR REGγ MDR JAK2 PSA DAPK MiRNA TET1 TSC1 MAPK DKK1 MMP ZEB2 RCC ARIDIA DMTF1 ARF MET SIRT MEG3 miRNAs HO-1 Renal cell carcinoma TGF-β Wnt PAK5 ATF-2 OS VEGF STAT3 NAP1L1 Akt MLH1 P53 KLF6 ccRCC HER PDCD4 KRAS MTA-1 Caki-1-SR EZH2
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!